ZOOMETF

This brand name is authorized in Nigeria.

Active ingredients

The drug ZOOMETF contains one active pharmaceutical ingredient (API):

1
UNII 786Z46389E - METFORMIN HYDROCHLORIDE
 

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

 
Read more about Metformin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
C4-1439 Tablet Zoometf Tablets TAB 500 mg Each tablet contains: Metformin Hydrochloride BP 500 mg 21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10BA02 Metformin A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database C4-1439

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.